
Agreement - October 12, 2021
Salipro Biotech in agreement with AbCellera
Salipro Biotech enters into a collaboration and license agreement with AbCellera for access to the Salipro platform for antibody discovery against GPCRs, ion channels, and transporters. The collaboration enables AbCellera to access Salipro Biotech’s expertise and its Salipro platform technology to generate stable antigens for challenging membrane protein drug targets for antibody discovery, the company […]